Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS finalizes e-prescribing standards

Executive Summary

Although pilot testing questioned the usefulness of pharmacies alerting physicians of the status of whether a prescription was filled, prescriber comments to the proposed e-prescribing standards rule "indicate that they perceived real value in RxFill for prescribers whose patients with chronic conditions may benefit from closer medication adherence monitoring," CMS said in its final e-prescribing standards under Medicare Part D rule. The final rule, scheduled to be published April 7, does not make the use of e-prescribing mandatory, but requires the use of the standards for those who engage in electronic prescribing. Five other standards that were proposed in a Nov. 16, 2007 rule are adopted in the 1final rule (2"The Pink Sheet," Nov. 19, 2007, p. 19). The rule also establishes a compliance date of one year after the publication of the final standards...

You may also be interested in...



Novartis’ Analytic Capabilities A Key Part Of WellPoint Health IT Pilot

Although pharmaceutical industry participation may not be critical in terms of rolling out a comprehensive health information technology program, WellPoint sees clear advantages to bringing in drug manufacturers and is currently working with Novartis to help analyze a new program the insurer is developing

Medicare E-Prescribing Adds Formulary Rules But Prior Auth Needs More Testing

Medicare's electronic prescribing standards would be expanded to include several components related to formulary coverage but standards on prior authorization need further development, CMS says in Nov. 16 proposed regulations

California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation

CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049474

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel